Grupo Español De Investigación En Neurooncología

This study tests a drug called tuvusertib in people whose IDH-mutant astrocytoma (a type of brain tumor) has returned after initial treatment. The drug targets a specific genetic change (ATRX mutation) to try to stop the tumor from growing. About 56 adults will take part, and the…